Cargando…
Reply: Somatic mutations are present in all members of the AKT family in endometrial carcinoma
Autores principales: | Shoji, K, Oda, K, Nakagawa, S, Hosokawa, S, Nagae, G, Uehara, Y, Sone, K, Miyamoto, Y, Hiraike, H, Hiraike-Wada, O, Nei, T, Kawana, K, Kuramoto, H, Aburatani, H, Yano, T, Taketani, Y |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768096/ http://dx.doi.org/10.1038/sj.bjc.6605302 |
Ejemplares similares
-
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
por: Shoji, K, et al.
Publicado: (2009) -
Identification of DBC1 as a transcriptional repressor for BRCA1
por: Hiraike, H, et al.
Publicado: (2010) -
Multifunctional transcription factor TFII-I is an activator of BRCA1 function
por: Tanikawa, M, et al.
Publicado: (2011) -
Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
por: Shoji, Keiko, et al.
Publicado: (2012) -
The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor α
por: Wada-Hiraike, O, et al.
Publicado: (2005)